XNCR.NASDAQXencor INC

Form 4: Xencor Director Barbara Klencke Acquires Shares and Stock Options

Sentiment:

SEC Form 4 Filing


Director Barbara Klencke acquired common stock and stock options in Xencor Inc on June 13, 2024.

Summary

  • On June 13, 2024, Barbara Klencke, a director of Xencor Inc, acquired 5,986 shares of common stock.
  • These shares were acquired as restricted stock units, which will fully vest on the first anniversary of the grant date.
  • Klencke also acquired stock options for 11,971 shares of common stock with an exercise price of $21.31.
  • These options vest in equal monthly installments over one year, beginning on July 13, 2024, and will be fully vested by June 13, 2025.
  • Following these transactions, Klencke directly owns 5,986 shares of common stock and has options for 11,971 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by a director suggests confidence, but it's a routine transaction.

Positives

  • The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedules for the acquired securities suggest a continued relationship between the director and the company over the next year.

Industry Context

Form 4 filings are routine disclosures of insider transactions and provide transparency into the trading activities of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Comparison to Industry Standards

  • Insider transactions are common across publicly traded companies.
  • The vesting schedule of one year for both the restricted stock units and stock options is fairly standard.
  • Comparing the size of this transaction to similar transactions by directors in comparable biotech companies would provide further context.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment, as it signals insider confidence.
  • There is no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
06/13/2024Date of transaction: Acquisition of common stock and stock options.
07/13/2024First monthly vesting date for stock options.
06/13/2025Full vesting date for both restricted stock units and stock options.
06/12/2034Expiration date for the stock options.
06/17/2024Date of filing the Form 4.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.